* We recommend a score >= 0.08 for meaningful Gene-Disease associations
GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | ![]() | DisGeNet_sourceDB |
5347 | PLK1 | C0017638 | Glioma | 0.200824180352639 | BEFREE;CTD_human |
5347 | PLK1 | C0023418 | leukemia | 0.200824180352639 | BEFREE;CTD_human |
5347 | PLK1 | C0006142 | Malignant neoplasm of breast | 0.0089349588097725 | BEFREE;GAD |
5347 | PLK1 | C0033578 | Prostatic Neoplasms | 0.0062900052822668 | BEFREE;LHGDN |
5347 | PLK1 | C0600139 | Prostate carcinoma | 0.0041209017631965 | BEFREE |
5347 | PLK1 | C0678222 | Breast Carcinoma | 0.0041209017631965 | BEFREE |
5347 | PLK1 | C0376358 | Malignant neoplasm of prostate | 0.0038461749789834 | BEFREE |
5347 | PLK1 | C0242379 | Malignant neoplasm of lung | 0.0037806624443535 | BEFREE;GAD |
5347 | PLK1 | C0007137 | Squamous cell carcinoma | 0.00355709281745305 | BEFREE;LHGDN |
5347 | PLK1 | C0596263 | Carcinogenesis | 0.0032967214105572 | BEFREE |
5347 | PLK1 | C0007133 | Carcinoma, Papillary | 0.00300763924902685 | BEFREE;LHGDN |
5347 | PLK1 | C0009375 | Colonic Neoplasms | 0.00300763924902685 | BEFREE;LHGDN |
5347 | PLK1 | C0040136 | Thyroid Neoplasm | 0.00300763924902685 | BEFREE;LHGDN |
5347 | PLK1 | C0005684 | Malignant neoplasm of urinary bladder | 0.0029564820917142 | BEFREE;GAD |
5347 | PLK1 | C0009404 | Colorectal Neoplasms | 0.00273291246481375 | LHGDN |
5347 | PLK1 | C0024299 | Lymphoma | 0.00273291246481375 | LHGDN |
5347 | PLK1 | C0030297 | Pancreatic Neoplasm | 0.00273291246481375 | LHGDN |
5347 | PLK1 | C0038356 | Stomach Neoplasms | 0.00273291246481375 | LHGDN |
5347 | PLK1 | C0079731 | B-Cell Lymphomas | 0.00273291246481375 | LHGDN |
5347 | PLK1 | C1140680 | Malignant neoplasm of ovary | 0.0026817553075011 | BEFREE;GAD |
5347 | PLK1 | C0009402 | Colorectal Carcinoma | 0.0024725410579179 | BEFREE |
5347 | PLK1 | C1527249 | Colorectal Cancer | 0.0024725410579179 | BEFREE |
5347 | PLK1 | C2239176 | Liver carcinoma | 0.0024725410579179 | BEFREE |
5347 | PLK1 | C0018671 | Head and Neck Neoplasms | 0.002407028523288 | GAD |
5347 | PLK1 | C0024117 | Chronic Obstructive Airway Disease | 0.002407028523288 | GAD |
5347 | PLK1 | C0027643 | Neoplasm Recurrence, Local | 0.002407028523288 | GAD |
5347 | PLK1 | C0085183 | Neoplasms, Second Primary | 0.002407028523288 | GAD |
5347 | PLK1 | C0178874 | Tumor Progression | 0.0019230874894917 | BEFREE |
5347 | PLK1 | C0007131 | Non-Small Cell Lung Carcinoma | 0.0016483607052786 | BEFREE |
5347 | PLK1 | C0017636 | Glioblastoma | 0.0016483607052786 | BEFREE |
5347 | PLK1 | C0025202 | melanoma | 0.0016483607052786 | BEFREE |
5347 | PLK1 | C0029463 | Osteosarcoma | 0.0016483607052786 | BEFREE |
5347 | PLK1 | C0027627 | Neoplasm Metastasis | 0.0013736339210655 | BEFREE |
5347 | PLK1 | C0280100 | solid tumor | 0.0013736339210655 | BEFREE |
5347 | PLK1 | C0585442 | Osteosarcoma of bone | 0.0013736339210655 | BEFREE |
5347 | PLK1 | C0684249 | Carcinoma of lung | 0.0013736339210655 | BEFREE |
5347 | PLK1 | C1306460 | Primary malignant neoplasm of lung | 0.0013736339210655 | BEFREE |
5347 | PLK1 | C1621958 | Glioblastoma Multiforme | 0.0013736339210655 | BEFREE |
5347 | PLK1 | C0007102 | Malignant tumor of colon | 0.0010989071368524 | BEFREE |
5347 | PLK1 | C0023467 | Leukemia, Myelocytic, Acute | 0.0010989071368524 | BEFREE |
5347 | PLK1 | C0027819 | Neuroblastoma | 0.0010989071368524 | BEFREE |
5347 | PLK1 | C0235974 | Pancreatic carcinoma | 0.0010989071368524 | BEFREE |
5347 | PLK1 | C0279626 | Squamous cell carcinoma of esophagus | 0.0010989071368524 | BEFREE |
5347 | PLK1 | C0346647 | Malignant neoplasm of pancreas | 0.0010989071368524 | BEFREE |
5347 | PLK1 | C0699790 | Colon Carcinoma | 0.0010989071368524 | BEFREE |
5347 | PLK1 | C0004135 | Ataxia Telangiectasia | 0.0008241803526393 | BEFREE |
5347 | PLK1 | C0019163 | Hepatitis B | 0.0008241803526393 | BEFREE |
5347 | PLK1 | C0025149 | Medulloblastoma | 0.0008241803526393 | BEFREE |
5347 | PLK1 | C0035412 | Rhabdomyosarcoma | 0.0008241803526393 | BEFREE |
5347 | PLK1 | C0152018 | Esophageal carcinoma | 0.0008241803526393 | BEFREE |
5347 | PLK1 | C0376545 | Hematologic Neoplasms | 0.0008241803526393 | BEFREE |
5347 | PLK1 | C0700095 | Central neuroblastoma | 0.0008241803526393 | BEFREE |
5347 | PLK1 | C1458155 | Mammary Neoplasms | 0.0008241803526393 | BEFREE |
5347 | PLK1 | C3539878 | Triple Negative Breast Neoplasms | 0.0008241803526393 | BEFREE |
5347 | PLK1 | C0005695 | Bladder Neoplasm | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0007134 | Renal Cell Carcinoma | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0014859 | Esophageal Neoplasms | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0019829 | Hodgkin Disease | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0023449 | Acute lymphocytic leukemia | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0023903 | Liver neoplasms | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0024623 | Malignant neoplasm of stomach | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0026764 | Multiple Myeloma | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0029925 | Ovarian Carcinoma | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0035335 | Retinoblastoma | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0085281 | Addictive Behavior | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0302592 | Cervix carcinoma | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0345904 | Malignant neoplasm of liver | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0546837 | Malignant neoplasm of esophagus | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0699791 | Stomach Carcinoma | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0699885 | Carcinoma of bladder | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.0005494535684262 | BEFREE |
5347 | PLK1 | C0001418 | Adenocarcinoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0001430 | Adenoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0002395 | Alzheimer's Disease | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0002726 | Amyloidosis | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0002793 | Anaplasia | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0006413 | Burkitt Lymphoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0007113 | Rectal Carcinoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0010633 | Cystadenoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0010709 | Cyst | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0014175 | Endometriosis | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0019189 | Hepatitis, Chronic | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0021051 | Immunologic Deficiency Syndromes | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0023452 | Leukemia, Lymphocytic, Acute, L1 | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0023461 | Leukemia, Mast-Cell | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0023470 | Myeloid Leukemia | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0023473 | Myeloid Leukemia, Chronic | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0023827 | liposarcoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0024121 | Lung Neoplasms | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0024301 | Lymphoma, Follicular | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0024305 | Lymphoma, Non-Hodgkin | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0025958 | Microcephaly | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0027533 | Neck Neoplasms | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0030389 | Parainfluenza | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0079773 | Lymphoma, T-Cell, Cutaneous | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0149925 | Small cell carcinoma of lung | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0151468 | Thyroid Gland Follicular Adenoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0151546 | Oral Cavity Carcinoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0152013 | Adenocarcinoma of lung (disorder) | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0153381 | Malignant neoplasm of mouth | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0153392 | Malignant neoplasm of nasopharynx | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0153633 | Malignant neoplasm of brain | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0205647 | Follicular adenoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0205824 | Liposarcoma, Dedifferentiated | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0206624 | Hepatoblastoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0206655 | Alveolar rhabdomyosarcoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0206743 | Rhabdoid Tumor | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0220641 | Lip and Oral Cavity Carcinoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0220650 | Metastatic malignant neoplasm to brain | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0220668 | Congenital contractural arachnodactyly | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0221013 | Mastocytosis, Systemic | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0238301 | Cancer of Nasopharynx | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0238461 | Anaplastic thyroid carcinoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0278488 | Carcinoma breast stage IV | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0278510 | Medulloblastoma, Childhood | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0278701 | Gastric Adenocarcinoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0279628 | Adenocarcinoma Of Esophagus | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0281361 | Adenocarcinoma of pancreas | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0282612 | Prostatic Intraepithelial Neoplasias | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0333516 | Tumor necrosis | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0338106 | Adenocarcinoma of colon | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0345967 | Malignant mesothelioma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0376544 | Hematopoietic Neoplasms | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0476089 | Endometrial Carcinoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0549473 | Thyroid carcinoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0553580 | Ewings sarcoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0553723 | Squamous cell carcinoma of skin | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0595989 | Carcinoma of larynx | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0598766 | Leukemogenesis | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0598935 | Tumor Initiation | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0686619 | Secondary malignant neoplasm of lymph node | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0740457 | Malignant neoplasm of kidney | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C0853879 | Invasive carcinoma of breast | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C1261473 | Sarcoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C1266050 | Poorly Differentiated Thyroid Carcinoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C1290375 | Mesothelioma (malignant, clinical disorder) (disorder) | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C1319314 | Transitional cell carcinoma of kidney | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C1378703 | Renal carcinoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C1512409 | Hepatocarcinogenesis | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C1535510 | ADENOMAS AND ADENOCARCINOMAS | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C1535926 | Neurodevelopmental Disorders | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C1704272 | Benign Prostatic Hyperplasia | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C1708566 | Invasive Prostate Carcinoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C1709246 | Non-Neoplastic Disorder | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C2931822 | Nasopharyngeal carcinoma | 0.0002747267842131 | BEFREE |
5347 | PLK1 | C3714948 | PACHYONYCHIA CONGENITA 3 | 0.0002747267842131 | BEFREE |